Nakatsuji K - Search Results

1

Effect of the novel orally active angiotensin converting enzyme inhibitor alacepril on cardiovascular system in experimental animals.

Takeyama K, Minato H, Nakatsuji K, Suzuki H, Nose I, Oka M, Hosoki K, Hatano N, Kadokawa T. Takeyama K, et al. Among authors: nakatsuji k. Arzneimittelforschung. 1986;36(1):69-73. Arzneimittelforschung. 1986. PMID: 3513779

2

General pharmacology of the novel antiepileptic compound zonisamide. 2nd communication: effects on cardiovascular, visceral, renal and blood functions.

Nakatsuji K, Matsuno Y, Nakamura N, Fujitani B, Ito T, Kadokawa T. Nakatsuji K, et al. Arzneimittelforschung. 1987 Oct;37(10):1131-6. Arzneimittelforschung. 1987. PMID: 3435584

3

Pharmacological studies of a new anti-inflammatory drug, 1-phenylsulfonyl-5,5-diphenylhydantoin (PC-796) in experimental animals. I. Anti-inflammatory, analgesic and anti-pyretic activity.

Nakamura H, Kadokawa T, Nakatsuji K, Nakamura K. Nakamura H, et al. Among authors: nakatsuji k. Arzneimittelforschung. 1970 Aug;20(8):1032-46. Arzneimittelforschung. 1970. PMID: 5536496 No abstract available.

4

Neuropharmacological and toxicological studies on a new anti-epileptic, N-alpha-ethyl-phenylacetyl-N'-acetyl urea in experimental animals.

Nakamura K, Murai K, Nakatsuji K, Kobayashi M, Masuda Y, Kadokawa T, Soji Y, Nakamura H, Hirooka T, Senda H. Nakamura K, et al. Among authors: nakatsuji k. Arzneimittelforschung. 1968 May;18(5):524-9. Arzneimittelforschung. 1968. PMID: 5755877 No abstract available.

5

Pharmacological evaluation of OP 1206, a prostaglandin E1 derivative, as an antianginal agent.

Tsuboi T, Hatano N, Nakatsuji K, Fujitani B, Yoshida K, Shimizu M, Kawasaki A, Sakata M, Tsuboshima M. Tsuboi T, et al. Among authors: nakatsuji k. Arch Int Pharmacodyn Ther. 1980 Sep;247(1):89-102. Arch Int Pharmacodyn Ther. 1980. PMID: 7447563

6

Preventive effect of a new calcium antagonist, monatepil, on drug-induced ischaemic electrocardiographic changes in rats.

Yamamoto T, Nakatsuji K, Hosoki K, Karasawa T. Yamamoto T, et al. Among authors: nakatsuji k. Clin Exp Pharmacol Physiol. 1993 Nov;20(11):673-8. doi: 10.1111/j.1440-1681.1993.tb01651.x. Clin Exp Pharmacol Physiol. 1993. PMID: 8306512

7

Effects of 5-HT(4) receptor agonists, cisapride and mosapride citrate on electrocardiogram in anaesthetized rats and guinea-pigs and conscious cats.

Kii Y, Nakatsuji K, Nose I, Yabuuchi M, Mizuki Y, Ito T. Kii Y, et al. Among authors: nakatsuji k. Pharmacol Toxicol. 2001 Aug;89(2):96-103. doi: 10.1034/j.1600-0773.2001.d01-142.x. Pharmacol Toxicol. 2001. PMID: 11555327

8

General pharmacology of recombinant human tumor necrosis factor. 1st communication: effects on cardiovascular, gastrointestinal, renal and blood functions.

Nakatsuji K, Kii Y, Fujitani B, Ito T. Nakatsuji K, et al. Arzneimittelforschung. 1990 Feb;40(2 Pt 1):218-25. Arzneimittelforschung. 1990. PMID: 2334464

9

Pharmacological evaluation of ONO 1206, a prostaglandin E1 derivative, as antianginal agent.

Tsuboi T, Hatano N, Nakatsuji K, Fujitani B, Yoshida K, Shimizu M, Kawasaki A, Sakata M, Tsuboshima M. Tsuboi T, et al. Among authors: nakatsuji k. Adv Prostaglandin Thromboxane Res. 1980;6:347-9. Adv Prostaglandin Thromboxane Res. 1980. PMID: 7386273 No abstract available.

10

General pharmacology of recombinant human tumor necrosis factor. 2nd communication: effects on central nervous system functions.

Kurumiya S, Miura Y, Nakatsuji K, Dodo M, Hori M, Ito T. Kurumiya S, et al. Among authors: nakatsuji k. Arzneimittelforschung. 1990 Feb;40(2 Pt 1):225-31. Arzneimittelforschung. 1990. PMID: 2334465

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters